Vertex Pharmaceuticals (VRTX) Profit Margin History

Historical gross, operating and net quarterly profit margin for Vertex Pharmaceuticals (VRTX) over the last 10 years. The current net profit margin for Vertex Pharmaceuticals as of November 17, 2017 is 8.53%.

Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $37.280B $1.702B
Vertex Pharmaceuticals Inc. discovers, develops and markets small molecule drugs that address major unmet medical needs. The company has eight drug candidates in clinical development to treat viral diseases, inflammation, cancer, autoimmune diseases and neurological disorders. Vertex has created its pipeline using a proprietary information-based approach to drug design that integrates multiple technologies in biology, chemistry and biophysics aimed at increasing the speed and success rate of drug discovery. (PRESS RELEASE)